Abstract
Detection and manipulation of direct cell–cell contact in complex tissues is a fundamental and challenging problem in many biological studies. Here, we report an optimized Notch-based synthetic receptor (synNQ) useful to study direct cell–cell interactions in Drosophila. With the synNQ system, cells expressing a synthetic receptor, which contains Notch activation machinery and a downstream transcriptional activator, QF, are activated by a synthetic GFP ligand expressed by contacting neighbor cells. To avoid cis-inhibition, mutually exclusive expression of the synthetic ligand and receptor is achieved using the “flippase-out” system. Expression of the synthetic GFP ligand is controlled by the Gal4/UAS system for easy and broad applications. Using synNQ, we successfully visualized cell–cell interactions within and between most fly tissues, revealing previously undocumented cell–cell contacts. Importantly, in addition to detection of cells in contact with one another, synNQ allows for genetic manipulation in all cells in contact with a targeted cell population, which we demonstrate in the context of cell competition in developing wing disks. Altogether, the synNQ genetic system will enable a broad range of studies of cell contact in developmental biology. Significance Direct cell–cell contacts are critical to diverse biological processes in multicellular organisms, including stem cell differentiation, tissue morphogenesis, neurotransmission, tumorigenesis, and immunological responses. However, identifying interacting cells in vivo is still a challenging task in complex tissues. Here, we introduce a new genetic tool, synthetic Notch receptor (synNQ), for efficient visualization and genetic manipulation of neighboring cells in vivo. This tool is functional in most fly tissues and can be easily applied using the widely adapted UAS/Gal4 system. Using both randomly generated clones and tissue-specific Gal4 lines, we demonstrate the applications of the synNQ system.
Funding Information
  • HHS | NIH | National Institute on Drug Abuse (R21DA039582)
  • Howard Hughes Medical Institute (NA)
  • Damon Runyon Cancer Research Foundation (2124-12)